Recruiting Chronic Myeloid Leukemia Studies in Chicago
About Chronic Myeloid Leukemia Clinical Trials in Chicago
Chronic myeloid leukemia (CML) is a type of cancer that starts in blood-forming cells of the bone marrow, characterized by the Philadelphia chromosome and BCR-ABL fusion gene. It was one of the first cancers treated successfully with targeted therapy. Tyrosine kinase inhibitors like imatinib have transformed CML into a manageable chronic condition.
There are currently 2 chronic myeloid leukemia clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 38 participants. Research is being sponsored by University of Chicago. Clinical trial participation is free and participants receive study-related medical care at no cost.
Chronic Myeloid Leukemia Clinical Trials in Chicago — FAQ
Are there chronic myeloid leukemia clinical trials in Chicago?
Yes, there are 2 chronic myeloid leukemia clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What chronic myeloid leukemia treatments are being tested?
The 2 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for chronic myeloid leukemia.
Data updated October 15, 2026 from ClinicalTrials.gov